Incidental SVT in cancer patients
| Reference . | Study design . | Cancer patients (N) . | Cancer type . | Scanner . | Patients with incidental SVT, n (%) . | Site of SVT, n . |
|---|---|---|---|---|---|---|
| 44 | Prospective | 1090 | Mixed | NR | 3 (0.27) | Superior mesenteric vein = 1 |
| Pelvic = 1 | ||||||
| Gonadal = 1 | ||||||
| 6 | Retrospective | 207 | Lung | NR | 3 (1.45) | Portal vein = 2 |
| Hepatic vein = 1 | ||||||
| 10 | Retrospective | 135 | Pancreas | NR | 31 (22.96) | 47 DVTs* |
| Portal vein = 18 | ||||||
| Splenic = 14 | ||||||
| Superior mesenteric vein = 11 | ||||||
| Inferior mesenteric vein = 4 | ||||||
| Hepatic = 1 | ||||||
| Gonadal = 1 | ||||||
| 12 | Retrospective | 1331 | Mixed | PET-CT | 2 (0.15) | Portal vein = 1 |
| Superior mesenteric vein = 1 | ||||||
| 57 | Retrospective | 838 | Mixed | NR | 8 (0.95) | Portal vein = 5 |
| Superior mesenteric vein = 3 | ||||||
| Renal vein = 1 | ||||||
| 58 | Retrospective | 1442 | Mixed | 64-row MDCT | 36 (2.5) | NR |
| Reference . | Study design . | Cancer patients (N) . | Cancer type . | Scanner . | Patients with incidental SVT, n (%) . | Site of SVT, n . |
|---|---|---|---|---|---|---|
| 44 | Prospective | 1090 | Mixed | NR | 3 (0.27) | Superior mesenteric vein = 1 |
| Pelvic = 1 | ||||||
| Gonadal = 1 | ||||||
| 6 | Retrospective | 207 | Lung | NR | 3 (1.45) | Portal vein = 2 |
| Hepatic vein = 1 | ||||||
| 10 | Retrospective | 135 | Pancreas | NR | 31 (22.96) | 47 DVTs* |
| Portal vein = 18 | ||||||
| Splenic = 14 | ||||||
| Superior mesenteric vein = 11 | ||||||
| Inferior mesenteric vein = 4 | ||||||
| Hepatic = 1 | ||||||
| Gonadal = 1 | ||||||
| 12 | Retrospective | 1331 | Mixed | PET-CT | 2 (0.15) | Portal vein = 1 |
| Superior mesenteric vein = 1 | ||||||
| 57 | Retrospective | 838 | Mixed | NR | 8 (0.95) | Portal vein = 5 |
| Superior mesenteric vein = 3 | ||||||
| Renal vein = 1 | ||||||
| 58 | Retrospective | 1442 | Mixed | 64-row MDCT | 36 (2.5) | NR |
*Events.